Skip to main content
Top
Published in: BMC Health Services Research 1/2016

Open Access 01-12-2016 | Research article

Regional differences in recommended cancer treatment for the elderly

Authors: Vivian Ho, Meei-Hsiang Ku-Goto, Hui Zhao, Karen E. Hoffman, Benjamin D. Smith, Sharon H. Giordano

Published in: BMC Health Services Research | Issue 1/2016

Login to get access

Abstract

Background

Little is known about regional variation in cancer treatment and its determinants. We compare rates of adherence to treatment guidelines for elderly patients across Texas and whether local specialist supply is an important determinant of treatment variation.

Methods

Previous literature reviewed indicated 7 recommended courses of treatment for colorectal, pancreatic, and prostate cancer. We analyzed Texas Cancer Registry data linked with Medicare claims for the years 2004 to 2007 to study patients with these cancers. We tested for unadjusted and adjusted differences in treatment rates across 22 hospital referral regions (HRR). We tested whether variation in the local supply of specialists treating each cancer was an important determinant of treatment.

Results

We found significant differences in adjusted treatment rates across regions. For removal and examination of 12+ lymph nodes with colon cancer resection, 13 of 22 HRRs had rates significantly different from the median region. For adjuvant chemotherapy for regional colon cancer, five HRRs significantly differed from the median. For prostate cancer treatment with a favorable diagnosis, nine HRRs differed from the median HRR. Of the 7 treatments, only the local availability of surgeons was an important determinant for excision of lymph nodes for colon cancer patients.

Conclusions

There are significant variations across Texas for seven recommended cancer treatments. No one region has consistently higher or lower treatments than other regions, and local specialist supply is not an important predictor of treatment. Different factors may be determining regional variation in treatment rates across cancer types and treatment options.
Appendix
Available only for authorised users
Literature
2.
go back to reference Anderson RT, Yang T, Matthews SA, Kern T, Mackley HB, Kimmick G, Louis C, Lengerich E, Yao N. Breast cancer screening, area deprivation, and later stage breast cancer in Appalachia: does geography matter? Health Serv Res. 2014;49:546–67.CrossRefPubMed Anderson RT, Yang T, Matthews SA, Kern T, Mackley HB, Kimmick G, Louis C, Lengerich E, Yao N. Breast cancer screening, area deprivation, and later stage breast cancer in Appalachia: does geography matter? Health Serv Res. 2014;49:546–67.CrossRefPubMed
3.
go back to reference Birkmeyer JD, Reames BN, McCulloch P, Carr AJ, Campbell WB, Wennberg JE. Understanding of regional variation in the use of surgery. Lancet. 2013;382:1121–9.CrossRefPubMedPubMedCentral Birkmeyer JD, Reames BN, McCulloch P, Carr AJ, Campbell WB, Wennberg JE. Understanding of regional variation in the use of surgery. Lancet. 2013;382:1121–9.CrossRefPubMedPubMedCentral
4.
go back to reference Coburn NG, Swallow CJ, Kiss A, Law C. Significant regional variation in adequacy of lymph node assessment and survival in gastric cancer. Cancer. 2006;107:2143–51.CrossRefPubMed Coburn NG, Swallow CJ, Kiss A, Law C. Significant regional variation in adequacy of lymph node assessment and survival in gastric cancer. Cancer. 2006;107:2143–51.CrossRefPubMed
5.
go back to reference Fairfield KM, Lucas FL, Earle CC, Small L, Trimble EL, Warren JL. Regional variation in cancer-directed surgery and mortality among women with epithelial ovarian cancer in the Medicare population. Cancer. 2010;116:4840–8.CrossRefPubMed Fairfield KM, Lucas FL, Earle CC, Small L, Trimble EL, Warren JL. Regional variation in cancer-directed surgery and mortality among women with epithelial ovarian cancer in the Medicare population. Cancer. 2010;116:4840–8.CrossRefPubMed
6.
go back to reference Feinstein AJ, Soulos PR, Long JB, Herrin J, Roberts KB, Yu JB, Gross CP. Variation in receipt of radiation therapy after breast-conserving surgery: assessing the impact of physicians and geographic regions. Med Care. 2013;51:330–8.CrossRefPubMedPubMedCentral Feinstein AJ, Soulos PR, Long JB, Herrin J, Roberts KB, Yu JB, Gross CP. Variation in receipt of radiation therapy after breast-conserving surgery: assessing the impact of physicians and geographic regions. Med Care. 2013;51:330–8.CrossRefPubMedPubMedCentral
7.
go back to reference Nattinger AB, Gottlieb MS, Veum J, Yahnke D, Goodwin JS. Geographic variation in the use of breast-conserving treatment for breast cancer. N Engl J Med. 1992;326:1102–7.CrossRefPubMed Nattinger AB, Gottlieb MS, Veum J, Yahnke D, Goodwin JS. Geographic variation in the use of breast-conserving treatment for breast cancer. N Engl J Med. 1992;326:1102–7.CrossRefPubMed
8.
go back to reference Reames BN, Sheetz KH, Waits SA, Dimick JB, Regenbogen SE. Geographic variation in use of laparoscopic colectomy for colon cancer. J Clin Oncol. 2014;32(32):3667–72.CrossRefPubMedPubMedCentral Reames BN, Sheetz KH, Waits SA, Dimick JB, Regenbogen SE. Geographic variation in use of laparoscopic colectomy for colon cancer. J Clin Oncol. 2014;32(32):3667–72.CrossRefPubMedPubMedCentral
9.
go back to reference Hoffman KE, Niu J, Shen Y, Jiang J, Davis JW, Kim J, Kuban DA, Perkins GH, Shah JB, Smith GL, Volk RJ, Buchholz TA, Giordano SH, Smith BD. Physician variation in management of Low-risk prostate cancer a population-based cohort study. JAMA Intern Med. 2014;174:1450–9.CrossRefPubMedPubMedCentral Hoffman KE, Niu J, Shen Y, Jiang J, Davis JW, Kim J, Kuban DA, Perkins GH, Shah JB, Smith GL, Volk RJ, Buchholz TA, Giordano SH, Smith BD. Physician variation in management of Low-risk prostate cancer a population-based cohort study. JAMA Intern Med. 2014;174:1450–9.CrossRefPubMedPubMedCentral
10.
go back to reference Xu X, Herrin J, Soulos PR, Saraf A, Roberts KB, Killelea BK, Wang S-Y, Long JB, Wang R, Ma X, Gross CP. The role of patient factors, cancer characteristics, and treatment patterns in the cost of care for medicare beneficiaries with breast cancer. Health Serv Res. 2016;51:167–86.CrossRefPubMed Xu X, Herrin J, Soulos PR, Saraf A, Roberts KB, Killelea BK, Wang S-Y, Long JB, Wang R, Ma X, Gross CP. The role of patient factors, cancer characteristics, and treatment patterns in the cost of care for medicare beneficiaries with breast cancer. Health Serv Res. 2016;51:167–86.CrossRefPubMed
11.
go back to reference Wennberg JE, Fisher ES, Skinner JS. Geography and the debate over Medicare Reform. Health Aff. 2002;Jul-Dec Suppl Web Exclusives:W96-114. Wennberg JE, Fisher ES, Skinner JS. Geography and the debate over Medicare Reform. Health Aff. 2002;Jul-Dec Suppl Web Exclusives:W96-114.
12.
go back to reference Zuckerman S, Waidmann T, Berenson R, Hadley J. Clarifying sources of geographic differences in Medicare spending. N Engl J Med. 2010;363:54–62.CrossRefPubMed Zuckerman S, Waidmann T, Berenson R, Hadley J. Clarifying sources of geographic differences in Medicare spending. N Engl J Med. 2010;363:54–62.CrossRefPubMed
13.
14.
go back to reference Adegboyega TO, Landercasper J, Linebarger JH, Johnson JM, Andersen JJ, Dietrich LL, Driscoll CD, Raghavendra M, Madadi AR, Al-Hamadani M, Vang CA, Marcou KA, Hudak J, Go RS. Institutional review of compliance with NCCN guidelines for breast cancer: Lessons learned from real-time multidimensional synoptic reporting. J Natl Compr Cancer Netw. 2015;13:177–83. Adegboyega TO, Landercasper J, Linebarger JH, Johnson JM, Andersen JJ, Dietrich LL, Driscoll CD, Raghavendra M, Madadi AR, Al-Hamadani M, Vang CA, Marcou KA, Hudak J, Go RS. Institutional review of compliance with NCCN guidelines for breast cancer: Lessons learned from real-time multidimensional synoptic reporting. J Natl Compr Cancer Netw. 2015;13:177–83.
15.
go back to reference Bilimoria KY, Bentrem DJ, Ko CY, Stewart AK, Winchester DP, Talamonti MS. National failure to operate on early stage pancreatic cancer. Ann Surg. 2007;246:173–80.CrossRefPubMedPubMedCentral Bilimoria KY, Bentrem DJ, Ko CY, Stewart AK, Winchester DP, Talamonti MS. National failure to operate on early stage pancreatic cancer. Ann Surg. 2007;246:173–80.CrossRefPubMedPubMedCentral
16.
go back to reference Hoffman KE, Niu J, Giordano SH, Ho V, Smith BD. Prostate cancer treatment patterns in the state of Texas, 2004–2007. Texas Public Heal J. 2013;65:37–43. Hoffman KE, Niu J, Giordano SH, Ho V, Smith BD. Prostate cancer treatment patterns in the state of Texas, 2004–2007. Texas Public Heal J. 2013;65:37–43.
17.
go back to reference Malin JL, Schneider EC, Epstein AM, Adams J, Emanuel EJ, Kahn KL. Results of the national initiative for cancer care quality: How can we improve the quality of cancer care in the United States? J Clin Oncol. 2006;24:626–34.CrossRefPubMed Malin JL, Schneider EC, Epstein AM, Adams J, Emanuel EJ, Kahn KL. Results of the national initiative for cancer care quality: How can we improve the quality of cancer care in the United States? J Clin Oncol. 2006;24:626–34.CrossRefPubMed
18.
go back to reference American Cancer Society. Cancer facts & figures 2015. Atlanta: American Cancer Society; 2015. American Cancer Society. Cancer facts & figures 2015. Atlanta: American Cancer Society; 2015.
19.
go back to reference Pathman DE, Ricketts TC, Konrad TR. How adults’ access to outpatient physician services relates to the local supply of primary care physicians in the rural southeast. Health Serv Res. 2006;41:79–102.CrossRefPubMedPubMedCentral Pathman DE, Ricketts TC, Konrad TR. How adults’ access to outpatient physician services relates to the local supply of primary care physicians in the rural southeast. Health Serv Res. 2006;41:79–102.CrossRefPubMedPubMedCentral
20.
go back to reference Ananthakrishnan AN, Hoffmann RG, Saeian K. Higher physician density is associated with lower incidence of late-stage colorectal cancer. J Gen Intern Med. 2010;25:1164–71.CrossRefPubMedPubMedCentral Ananthakrishnan AN, Hoffmann RG, Saeian K. Higher physician density is associated with lower incidence of late-stage colorectal cancer. J Gen Intern Med. 2010;25:1164–71.CrossRefPubMedPubMedCentral
21.
go back to reference Benarroch-Gampel J, Sheffield KM, Lin Y-L, Kuo Y-F, Goodwin JS, Riall TS. Colonoscopist and primary care physician supply and disparities in colorectal cancer screening. Health Serv Res. 2012;47(3 Pt 1):1137–57.CrossRefPubMed Benarroch-Gampel J, Sheffield KM, Lin Y-L, Kuo Y-F, Goodwin JS, Riall TS. Colonoscopist and primary care physician supply and disparities in colorectal cancer screening. Health Serv Res. 2012;47(3 Pt 1):1137–57.CrossRefPubMed
22.
go back to reference Coughlin SS, Leadbetter S, Richards T, Sabatino SA. Contextual analysis of breast and cervical cancer screening and factors associated with health care access among United States women, 2002. Soc Sci Med. 2008;66:260–75.CrossRefPubMed Coughlin SS, Leadbetter S, Richards T, Sabatino SA. Contextual analysis of breast and cervical cancer screening and factors associated with health care access among United States women, 2002. Soc Sci Med. 2008;66:260–75.CrossRefPubMed
23.
go back to reference Fleisher JM, Lou JQ, Farrell M. Relationship between physician supply and breast cancer survival: a geographic approach. J Community Health. 2008;33:179–82.CrossRefPubMed Fleisher JM, Lou JQ, Farrell M. Relationship between physician supply and breast cancer survival: a geographic approach. J Community Health. 2008;33:179–82.CrossRefPubMed
24.
go back to reference Gorey KM, Luginaah IN, Fung KY, Bartfay E, Hamm C, Wright FC, Balagurusamy M, Holowaty EJ. Physician supply and breast cancer survival. J Am Board Fam Med. 2010;23:104–8.CrossRefPubMedPubMedCentral Gorey KM, Luginaah IN, Fung KY, Bartfay E, Hamm C, Wright FC, Balagurusamy M, Holowaty EJ. Physician supply and breast cancer survival. J Am Board Fam Med. 2010;23:104–8.CrossRefPubMedPubMedCentral
25.
26.
go back to reference Onega T, Duell EJ, Shi X, Wang D, Demidenko E, Goodman D. Geographic access to cancer care in the U.S. Cancer. 2008;112:909–18.CrossRefPubMed Onega T, Duell EJ, Shi X, Wang D, Demidenko E, Goodman D. Geographic access to cancer care in the U.S. Cancer. 2008;112:909–18.CrossRefPubMed
29.
go back to reference Riall TS, Townsend CM, Kuo YF, Freeman JL, Goodwin JS. Dissecting racial disparities in the treatment of patients with locoregional pancreatic cancer: A 2-step process. Cancer. 2010;116:930–9.CrossRefPubMedPubMedCentral Riall TS, Townsend CM, Kuo YF, Freeman JL, Goodwin JS. Dissecting racial disparities in the treatment of patients with locoregional pancreatic cancer: A 2-step process. Cancer. 2010;116:930–9.CrossRefPubMedPubMedCentral
30.
go back to reference Bill-Axelson A, Holmberg L, Ruutu M, Haggman M, Andersson S-O, Bratell S, Spangberg A, Busch C, Nording S, Garmo H, Palmgren J, Adami H-O, Norlen BJ, Johansson J-E. Radical prostatectomy versus watchful waiting in early prostate cancer. N Engl J Med. 2005;352:1977–84.CrossRefPubMed Bill-Axelson A, Holmberg L, Ruutu M, Haggman M, Andersson S-O, Bratell S, Spangberg A, Busch C, Nording S, Garmo H, Palmgren J, Adami H-O, Norlen BJ, Johansson J-E. Radical prostatectomy versus watchful waiting in early prostate cancer. N Engl J Med. 2005;352:1977–84.CrossRefPubMed
31.
go back to reference Wilt TJ, Brawer MK, Jones KM, Barry MJ, Aronson WJ, Fox S, Gingrich JR, Wei JT, Gilhooly P, Grob M, Nsouli I, Iyer P, Cartagena R, Snider G, Roehrborn C, Sharifi R, Blank W, Pandya P, Andriole GL, Culkin D, Wheeler T. Radical prostatectomy versus observation for localized prostate cancer. N Engl J Med. 2012;367:203–13.CrossRefPubMedPubMedCentral Wilt TJ, Brawer MK, Jones KM, Barry MJ, Aronson WJ, Fox S, Gingrich JR, Wei JT, Gilhooly P, Grob M, Nsouli I, Iyer P, Cartagena R, Snider G, Roehrborn C, Sharifi R, Blank W, Pandya P, Andriole GL, Culkin D, Wheeler T. Radical prostatectomy versus observation for localized prostate cancer. N Engl J Med. 2012;367:203–13.CrossRefPubMedPubMedCentral
32.
go back to reference Bill-Axelson A, Holmberg L, Filen F, Ruutu M, Garmo H, Busch C, Nordling S, Haggman M, Andersson SO, Bratell S, Spangberg A, Palmgren J, Adami HO, Johansson J-E. Radical prostatectomy versus watchful waiting in localized prostate cancer: The Scandinavian prostate cancer group-4 randomized trial. J Natl Cancer Inst. 2008;100:1144–54.CrossRefPubMedPubMedCentral Bill-Axelson A, Holmberg L, Filen F, Ruutu M, Garmo H, Busch C, Nordling S, Haggman M, Andersson SO, Bratell S, Spangberg A, Palmgren J, Adami HO, Johansson J-E. Radical prostatectomy versus watchful waiting in localized prostate cancer: The Scandinavian prostate cancer group-4 randomized trial. J Natl Cancer Inst. 2008;100:1144–54.CrossRefPubMedPubMedCentral
35.
go back to reference Wennberg JE, Thomson PY. Time to tackle unwarranted variations in practice. BMJ. 2011;342:d1513.CrossRef Wennberg JE, Thomson PY. Time to tackle unwarranted variations in practice. BMJ. 2011;342:d1513.CrossRef
36.
go back to reference Wooldridge JM. Introductory econometrics: a modern approach. 4th ed. Mason: South-Western Cengage Learning; 2009. Wooldridge JM. Introductory econometrics: a modern approach. 4th ed. Mason: South-Western Cengage Learning; 2009.
37.
go back to reference Riall TS, Sheffield KM, Kuo Y-F, Townsend Jr CM, Goodwin JS. Resection benefits older adults with locoregional pancreatic cancer despite greater short-term morbidity and mortality. J Am Geriatr Soc. 2011;59:647–54.CrossRefPubMedPubMedCentral Riall TS, Sheffield KM, Kuo Y-F, Townsend Jr CM, Goodwin JS. Resection benefits older adults with locoregional pancreatic cancer despite greater short-term morbidity and mortality. J Am Geriatr Soc. 2011;59:647–54.CrossRefPubMedPubMedCentral
38.
go back to reference Baxter NN, Virnig DJ, Rothenberger DA, Morris AM, Jessurun J, Virnig BA. Lymph node evaluation in colorectal cancer patients: A population-based study. J Natl Cancer Inst. 2005;97:219–25.CrossRefPubMed Baxter NN, Virnig DJ, Rothenberger DA, Morris AM, Jessurun J, Virnig BA. Lymph node evaluation in colorectal cancer patients: A population-based study. J Natl Cancer Inst. 2005;97:219–25.CrossRefPubMed
40.
go back to reference Gawande A. Annals of Medicine: The Cost Conundrum: What A Texas town can teach us about health care. The New Yorker 2009:1–7. Gawande A. Annals of Medicine: The Cost Conundrum: What A Texas town can teach us about health care. The New Yorker 2009:1–7.
42.
go back to reference Hutchins LF, Unger JM, Crowley JJ, Coltman CA, Albain KS. Underrepresentation of patients 65 years of age or older in cancer treatment trials. N Engl J Med. 1999;341:2061–7.CrossRefPubMed Hutchins LF, Unger JM, Crowley JJ, Coltman CA, Albain KS. Underrepresentation of patients 65 years of age or older in cancer treatment trials. N Engl J Med. 1999;341:2061–7.CrossRefPubMed
44.
go back to reference Ward E, Halpern M, Schrag N, Cokkinides V, DeSantis C, Bandi P, Siegel R, Stewart A, Jemal A. Association of insurance with cancer care utilization and outcomes. CA Cancer J Clin. 2008;58:9–31.CrossRefPubMed Ward E, Halpern M, Schrag N, Cokkinides V, DeSantis C, Bandi P, Siegel R, Stewart A, Jemal A. Association of insurance with cancer care utilization and outcomes. CA Cancer J Clin. 2008;58:9–31.CrossRefPubMed
45.
go back to reference Cabana MD, Rand CS, Powe NR, Wu AW, Wilson MH, Abboud P-AC, Rubin HR. Why Don’t physicians follow clinical practice guidelines? a framework for improvement. J Am Med Assoc. 1999;282:1458–65.CrossRef Cabana MD, Rand CS, Powe NR, Wu AW, Wilson MH, Abboud P-AC, Rubin HR. Why Don’t physicians follow clinical practice guidelines? a framework for improvement. J Am Med Assoc. 1999;282:1458–65.CrossRef
46.
go back to reference Foster JA, Abdolrasulnia M, Doroodchi H, McClure J, Casebeer L. Practice patterns and guideline adherence of medical oncologists in managing patients with early breast cancer. J Natl Compr Cancer Netw. 2009;7:697–706. Foster JA, Abdolrasulnia M, Doroodchi H, McClure J, Casebeer L. Practice patterns and guideline adherence of medical oncologists in managing patients with early breast cancer. J Natl Compr Cancer Netw. 2009;7:697–706.
47.
go back to reference Blayney DW, Severson J, Martin CJ, Kadlubek P, Ruane T, Harrison K. Michigan oncology practices showed varying adherence rates to practice guidelines, but quality interventions improved care. Health Aff. 2012;31:718–28.CrossRef Blayney DW, Severson J, Martin CJ, Kadlubek P, Ruane T, Harrison K. Michigan oncology practices showed varying adherence rates to practice guidelines, but quality interventions improved care. Health Aff. 2012;31:718–28.CrossRef
48.
go back to reference Neubauer MA, Hoverman JR, Kolodziej M, Reisman L, Gruschkus SK, Hoang S, Alva AA, McArthur M, Forsyth M, Rothermel T, Beveridge RA. Cost effectiveness of evidence-based treatment guidelines for the treatment of non-small-cell lung cancer in the community setting. J Oncol Pract. 2010;6:12–8.CrossRefPubMed Neubauer MA, Hoverman JR, Kolodziej M, Reisman L, Gruschkus SK, Hoang S, Alva AA, McArthur M, Forsyth M, Rothermel T, Beveridge RA. Cost effectiveness of evidence-based treatment guidelines for the treatment of non-small-cell lung cancer in the community setting. J Oncol Pract. 2010;6:12–8.CrossRefPubMed
Metadata
Title
Regional differences in recommended cancer treatment for the elderly
Authors
Vivian Ho
Meei-Hsiang Ku-Goto
Hui Zhao
Karen E. Hoffman
Benjamin D. Smith
Sharon H. Giordano
Publication date
01-12-2016
Publisher
BioMed Central
Published in
BMC Health Services Research / Issue 1/2016
Electronic ISSN: 1472-6963
DOI
https://doi.org/10.1186/s12913-016-1534-z

Other articles of this Issue 1/2016

BMC Health Services Research 1/2016 Go to the issue